Skip to main content Accessibility help
×
Home

Predictors of Response to Lithium and Triiodothyronine Augmentation of Antidepressants in Tricyclic Non-responders

  • Russell T. Joffe (a1), Anthony J. Levitt (a1), R. Michael Bagby (a1), Cathy MacDonald (a1) and William Singer (a2)...

Abstract

Although both lithium and triiodothyronine (T3) augmentation strategies may be rapid, safe, and effective ways of treating patients who fail to respond to tricyclics, little is known about the clinical or biochemical correlates of response. We examined clinical and endocrine variables which distinguished T3 and lithium responders from each other and from non-responders in a post-hoc analysis of two studies involving 51 subjects who had received these augmentation strategies under double-blind conditions. Lithium non-responders were more severely depressed and had more insomnia and weight loss than responders. T3 responders could be distinguished from lithium responders by greater weight loss. There were no reliable clinical differences between T3 responders and non-responders. Thyroid function tests did not differ between any of the treatment or response groups. Our findings suggest that clinical but not endocrine variables may distinguish responders to these two augmentation strategies.

Copyright

Corresponding author

Clarke Institute of Psychiatry, 250 College Street, Toronto, Ontario, M5T 1R8, Canada

References

Hide All
Austin, M. P. V., Souza, F. G. N. & Goodwin, G. M. (1991) Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. British Journal of Psychiatry, 159, 510514.
Banki, C. M. (1975) Triiodothyronine in the treatment of depression. Orvieti Hetilia, 116, 25432547.
Banki, C. M. (1977) Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women. European Journal of Clinical Pharmacology, 11, 311315.
DeMontigny, C., Grunberg, F., Mayer, A., et al (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. British Journal of Psychiatry, 138, 252256.
DeMontigny, C., Cournoyer, G., Morisette, R., et al (1983) Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with the neurobiologie actions of tricyclic antidepressant drugs and lithium iron on the serotonin system. Archives of General Psychiatry, 40, 13271334.
Earle, B. V. (1970) Thyroid hormone and tricyclic antidepressants in resistant depression. American Journal of Psychiatry, 126, 16671669.
Garbutt, J. C., Mayo, J. P. Jr, Gillette, G. M., et al (1986) Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation. American Journal of Psychiatry, 143, 10381039.
Gitlin, M. J., Winer, H., Fairbanks, L., et al (1987) Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders, 13, 267272.
Goodwin, F. K., Prange, A. J. Jr, Post, R. M., et al (1982) Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. American Journal of Psychiatry, 139, 3438.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Heninger, G. R., Charney, D. S. & Sternberg, D. E. (1983) Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Archives of General Psychiatry, 40, 13351342.
Joffe, R. T. (1988) T3 and lithium potentiation of tricyclic antidepressants. American Journal of Psychiatry, 145, 13171318.
Joffe, R. T. & Singer, W. (1990) A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research, 32, 241252.
Joffe, R. T., Singer, W., Levitt, A. L., et al (1993) A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Archives of General Psychiatry, 50, 387394.
Kantor, D., McNeivin, S., Leichner, P., et al (1986) The benefit of lithium carbonate adjunct in refractory depression: fact or fiction? Canadian Journal of Psychiatry, 31, 416418.
Louie, A. K. & Meltzer, H. Y. (1984) Lithium potentiation of antidepressant treatment. Journal of Clinical Psychopharmacology, 4, 316321.
Nelson, J. C. & Mazure, C. M. (1986) Lithium augmentation in psychotic depression refractory to combine drug treatment. American Journal of Psychiatry, 143, 363366.
Ogura, C., Okuma, T., Uchida, Y., et al (1974) Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressed states. Folia Psychiatrica Neurologica Japonica, 28, 179186.
Price, L. H. (1988) Lithium augmentation and tricyclic-resistant depression. In Treatment of Tricyclic-Resistant Depression (ed. Extein, I.). Washington, DC: American Psychiatric Press.
Price, L. H., Charney, D. S. & Heninger, G. R. (1986) Variability of response to lithium augmentation and refractory depression. American Journal of Psychiatry, 143, 13871392.
Rhoades, H. M. & Overall, J. E. (1983) The Hamilton Depression Scale: factor scoring and profile classification. Psychopharmacology Bulletin, 19, 9196.
Schopf, J., Baumann, P., Lemarchand, T., et al (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry, 22, 183187.
Schou, M. (1990) Lithium and treatment-resistant depressions: a review. Lithium, 1, 38.
Schwarcz, G., Halaris, A., Baxter, L., et al (1984) Normal thyroid function in desipramine nonresponders compared to responders by the addition of L-triiodothyronine. American Journal of Psychiatry, 141, 16141616.
Spitzer, R. L. & Endicott, J. (1978) Schedule of Affective Disorders and Schizophrenia - Lifetime version (SADS-L). New York: State Psychiatric Institute, Biometrics Research.
Spitzer, R. L., & Robins, E. (1978) Research Diagnostic Criteria: rationale and reliability. Archives of General Psychiatry, 35, 773782.
Stein, G. & Bernaot, M. (1988) Double-blind trial of lithium carbonate in tricyclic resistant depression. In Lithium: Inorganic Pharmacology and Psychiatric Use (ed. Birch, N. J.). Oxford: IRL Press.
Tsutsui, S., Yamazaki, Y., Nanba, T., et al (1979) Combined therapy of T3 and antidepressants in depression. Journal of Internal Medicine Research, 7, 138146.
Thase, M. E., Kupfer, D. J. & Jarrett, D. B. (1989) Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385388.
Zusky, P. M., Biederman, J., Rosenbaum, J. F., et al (1988) Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. Journal of Clinical Psychopharmacology, 8, 120124.

Predictors of Response to Lithium and Triiodothyronine Augmentation of Antidepressants in Tricyclic Non-responders

  • Russell T. Joffe (a1), Anthony J. Levitt (a1), R. Michael Bagby (a1), Cathy MacDonald (a1) and William Singer (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Predictors of Response to Lithium and Triiodothyronine Augmentation of Antidepressants in Tricyclic Non-responders

  • Russell T. Joffe (a1), Anthony J. Levitt (a1), R. Michael Bagby (a1), Cathy MacDonald (a1) and William Singer (a2)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *